Full Text View
Tabular View
No Study Results Posted
Related Studies
Abciximab in Wake-up Stroke
This study has been terminated.
( Higher hemorrhage rates of Abciximab in ABESST II trial )
Study NCT00167765   Information provided by University of Zurich
First Received: September 9, 2005   Last Updated: May 1, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stroke
Additional conditions recognized in this trial
Cerebral Infarction
More general conditions related to this trial
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Nervous System Diseases
Vascular Diseases
Interventions listed in this trial
Abciximab
More general drug interventions related to this trial
Anticoagulants
Hematologic Agents
Pharmacologic Actions
Platelet Aggregation Inhibitors
Therapeutic Uses
Sponsors listed in this trial
University of Zurich
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services